Publication | Open Access
Bortezomib enhances radiosensitivity in oral cancer through inducing autophagy-mediated TRAF6 oncoprotein degradation
46
Citations
28
References
2018
Year
A combination of a proteasome inhibitor, IR treatment and TRAF6 inhibition could be a novel therapeutic strategy in OSCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1